Discovering New Drugs and Biomarkers for Alzheimer's Disease

Watch the latest Alzheimer’s Disease programs from the Brain Channel:

1761Embracing Innovation: Discovering New Drugs for Alzheimer’s Disease
How can we create more effective drugs for Alzheimer’s disease? Michael Jackson, PhD joins William Mobley, MD, PhD to discuss the process of turning an idea into a drug. Creating connectivity between basic scientists, pharmaceutical companies, and the physicians on the front lines is a critical step as is embracing new ideas that may lead us to new therapeutic options.


1761Seeking the Biomarkers of Alzheimer’s Disease
The biomarkers for many diseases can be found through blood tests, can Alzheimer’s disease eventually be diagnosed this way? Douglas R. Galasko, MD joins William Mobley, MD, PhD to discuss the search for these biomarkers and how they might one day lead to earlier and more accurate diagnoses of the disease, improved therapies, clear maps of progression, and much more.

The Brain Channel’s flagship series On Our Mind takes a closer look at Alzheimer’s disease. Join Dr. William Mobley as he meets with those on the front lines of this disease to discuss current and potential therapies, testing, clinical trials, neuropathology, public policy and so much more.

Watch all of the Alzheimer’s Disease programs.

791

New Alzheimer's Programs from the Brain Channel's On Our Mind

Alzheimer's Disease - On Our MindWatch the latest Alzheimer’s Disease programs from the Brain Channel!

The Brain Channel’s flagship series On Our Mind is endeavoring in the next few months to take a closer look at Alzheimer’s disease. Join Dr. William Mobley as he meets with those on the front lines of this disease to discuss current and potential therapies, testing, clinical trials, neuropathology, public policy and so much more.

Online now:

1761Diagnosing Alzheimer’s Disease
How do you know when memory problems become more than just problems? Diagnosing Alzheimer’s disease can be challenging but new tests and scientific insight are making the process simpler and more accurate. Michael Rafii, MD, PhD joins William Mobley, MD, PhD to discuss when to see a doctor, what to expect during the diagnosis process, and other valuable information for patients and their families.


1761Developing New Drugs for Alzheimer’s Disease
What does the future hold for the treatment of Alzheimer’s disease? Steven L. Wagner, PhD joins William Mobley, MD, PhD to discuss the development of new drugs to aid in the fight. Wagner describes amyloid plaques as “the cholesterol of the brain” and is working to find a way to suppress its adverse effects.


1761Down Syndrome and Alzheimer’s Disease
By the age of 40, nearly all people with Down syndrome have the plaques and tangles associated with Alzheimer’s disease. Michael Rafii, MD, PhD joins William Mobley, MD, PhD to discuss why this occurs, the prevalence and progression of Alzheimer’s disease, potential treatment models and current research affecting this predisposed population.


1761Detecting Alzheimer’s Disease Earlier and Effectively
Early detection of Alzheimer’s disease – before symptoms are visible – may be a key to stopping the disease’s progression. What warning signs are researchers looking for and what tools can they use? Paul Aisen, MD joins William Mobley, MD, PhD to discuss optimal assessments for diagnosing the disease, novel tools making earlier diagnosis possible, and the road map to developing drugs to slow, halt, and prevent Alzheimer’s.


Watch all the programs in this informative series and stay tuned for upcoming episodes.

On Our Mind – Alzheimer's Disease

Alzheimer's Disease - On Our Mind An estimated 5 million Americans have Alzheimer’s disease and that number will continue to rise. The impact will be felt not just in the homes of the diagnosed but by their caregivers, their loved ones, their communities, and beyond.

The Brain Channel’s flagship series On Our Mind is endeavoring in the next few months to take a closer look at Alzheimer’s disease. Join Dr. William Mobley as he meets with those on the front lines of this disease to discuss current and potential therapies, testing, clinical trials, neuropathology, public policy and so much more.

Online now:

1761Agenda: Alzheimer’s Disease Cure and Care
There are more than 5 million Americans living with Alzheimer’s disease. San Diego County Supervisor Dianne Jacob joins William Mobley, MD, PhD to discuss how we can better manage this disease from a public policy standpoint.


1761Stem Cells and Alzheimer’s Disease
Can stem cells be a weapon in the fight against Alzheimer’s disease? Larry Goldstein, PhD director the the UC San Diego Stem Cell Program, joins William Mobley, MD, PhD to discuss how stem cells work and what possibilities they may unlock.


1761The Anatomy of Memory
How do we create and store memories? Larry Squire PhD joins William Mobley MD, PhD to dissect these processes and how we might use this knowledge to aid in the fight against Alzheimer’s disease.


1761The Role of Synapses in Memory
Roberto Malinow, MD, PhD joins William Mobley MD, PhD to discuss his recent study where memories were not only erased but restored in rats. Learn how findings of this study could lead to breakthroughs in the treatment of Alzheimer’s disease.


Stay tuned to the Brain Channel for new installments in this informative series.